AI-generated summary
The authors studied mice given intratracheal lipopolysaccharide to induce acute lung injury, then treated some with 660 nm low level laser therapy. They report that the laser was associated with fewer inflammatory cells in the lungs and lower levels of inflammatory mediators, with no change in lung mechanical properties. The study was conducted in mice, so its relevance to humans is not established.
- Who or what was studied
- C57BL/6 mice with lipopolysaccharide-induced acute lung injury
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice, so findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 10 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Inflammation, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.